A Randomized Double Blind Placebo Controlled trial Evaluating the Efficacy of Alpha Lipoic Acid as Add-On Therapy on Cognitive Impairment in Schizophrenia Patients of a Tertiary Care Hospital - nil

Dr Ramya R0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•1)Schizophrenia diagnosis made by research psychiatrists using the Structured Clinical Interview, SCID-5, for Diagnostic and Statistical Manual of Mental Disorders of more than 2 years duration and on treatment
•2)Cognitive symptoms despite adequate antipsychotic treatment assessed by MOCA scored < 26
•3)Age 18-60 years of either gender
•4)Willing to participate

•1)6-months history of any drug or alcohol abuse or dependence
•2)Changes in psychotropic medications within the last 4 weeks and patients on valproate use (potential interaction with ALA)
•3)Women who are planning to become pregnant, are pregnant, or are breastfeeding
•4)Known chronic infections such as HIV or hepatitis C, and liver or renal failure that could adversely impact on patient outcome

发起方

Dr Ramya R